The effect of NFFD intervention on the glucose metabolism of normal-weight women is consistent with the findings of Vinter et al., who reported significantly lower insulin and HOMA-IR levels at gestational-week 28–30 following lifestyle intervention, but no significant differences in glucose levels or the incidence of GDM, albeit in an exclusively overweight/obese population [25]. Here, INS is linked to gestational diabetes.